Yale Jen
Stock Analyst at Laidlaw & Co.
(0.10)
# 4,503
Out of 5,146 analysts
15
Total ratings
6.67%
Success rate
-17.24%
Average return
Main Sectors:
Stocks Rated by Yale Jen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PTN Palatin Technologies | Initiates: Buy | $60 | $20.96 | +186.26% | 1 | Dec 12, 2025 | |
| FEMY Femasys | Initiates: Buy | $6.5 | $0.56 | +1,051.26% | 1 | Nov 20, 2025 | |
| NSRX Nasus Pharma | Initiates: Buy | $22 | $5.06 | +334.73% | 1 | Sep 29, 2025 | |
| SNTI Senti Biosciences | Initiates: Buy | $5 | $0.95 | +429.10% | 1 | Jun 6, 2025 | |
| SLNO Soleno Therapeutics | Maintains: Buy | $75 → $105 | $41.01 | +156.04% | 2 | Mar 27, 2025 | |
| NVCT Nuvectis Pharma | Initiates: Buy | $19 | $8.93 | +112.77% | 1 | Mar 17, 2025 | |
| LFWD Lifeward | Initiates: Buy | $120 | $6.02 | +1,893.36% | 1 | Feb 10, 2025 | |
| ABVX ABIVAX Société Anonyme | Initiates: Buy | $48 | $123.33 | -61.08% | 1 | Jul 29, 2024 | |
| PHGE BiomX | Initiates: Buy | $475 | $4.59 | +10,248.58% | 1 | May 28, 2024 | |
| INAB IN8bio | Initiates: Buy | $225 | $1.66 | +13,454.22% | 1 | Mar 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $6.81 | - | 2 | Dec 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $0.37 | +2,610.03% | 1 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $3.13 | - | 1 | Aug 15, 2023 |
Palatin Technologies
Dec 12, 2025
Initiates: Buy
Price Target: $60
Current: $20.96
Upside: +186.26%
Femasys
Nov 20, 2025
Initiates: Buy
Price Target: $6.5
Current: $0.56
Upside: +1,051.26%
Nasus Pharma
Sep 29, 2025
Initiates: Buy
Price Target: $22
Current: $5.06
Upside: +334.73%
Senti Biosciences
Jun 6, 2025
Initiates: Buy
Price Target: $5
Current: $0.95
Upside: +429.10%
Soleno Therapeutics
Mar 27, 2025
Maintains: Buy
Price Target: $75 → $105
Current: $41.01
Upside: +156.04%
Nuvectis Pharma
Mar 17, 2025
Initiates: Buy
Price Target: $19
Current: $8.93
Upside: +112.77%
Lifeward
Feb 10, 2025
Initiates: Buy
Price Target: $120
Current: $6.02
Upside: +1,893.36%
ABIVAX Société Anonyme
Jul 29, 2024
Initiates: Buy
Price Target: $48
Current: $123.33
Upside: -61.08%
BiomX
May 28, 2024
Initiates: Buy
Price Target: $475
Current: $4.59
Upside: +10,248.58%
IN8bio
Mar 18, 2024
Initiates: Buy
Price Target: $225
Current: $1.66
Upside: +13,454.22%
Dec 22, 2023
Downgrades: Hold
Price Target: n/a
Current: $6.81
Upside: -
Aug 28, 2023
Initiates: Buy
Price Target: $10
Current: $0.37
Upside: +2,610.03%
Aug 15, 2023
Downgrades: Hold
Price Target: n/a
Current: $3.13
Upside: -